VEA
QTTB icon

Virtus ETF Advisers’s Q32 Bio QTTB Stock Holding History

Virtus ETF Advisers’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,972
Closed -$108K – 481
2022
Q1 		$108K Sell
1,972
-116
-6% -$7.21K 0.05% 291
2021
Q4 		$137K Buy
2,088
+489
+31% +$47.5K 0.05% 363
2021
Q3 		$226K Sell
1,599
-83
-5% -$10.6K 0.1% 238
2021
Q2 		$220K Buy
1,682
+288
+21% +$35.9K 0.09% 277
2021
Q1 		$236K Buy
1,394
+25
+2% +$5.26K 0.1% 300
2020
Q4 		$278K Buy
1,369
+216
+19% +$41.8K 0.12% 253
2020
Q3 		$222K Sell
1,153
-157
-12% -$35.2K 0.12% 285
2020
Q2 		$358K Buy
1,310
+346
+36% +$92.2K 0.17% 257
2020
Q1 		$270K Sell
964
-142
-13% -$43.5K 0.11% 240
2019
Q4 		$412K Buy
+1,106
New +$317K 0.07% 244

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Virtus ETF Advisers's QTTB Position: Q2 2022 in Review

Virtus ETF Advisers sold out of Q32 Bio (QTTB) in Q2 2022, closing a stake of 1,972 shares — an estimated $108K sold.

Virtus ETF Advisers first reported a position in QTTB in Q4 2019 and held it in 10 quarters. The position peaked at $412K in Q4 2019. 87 funds tracked by Wall St. Rank hold QTTB as of Q2 2022.

  • Virtus ETF Advisers reported no remaining Q32 Bio position as of Q2 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 1,972 Q32 Bio shares in Q2 2022, an estimated $108K.
  • Virtus ETF Advisers first reported a position in Q32 Bio in Q4 2019 and held it in 10 quarters.
  • Virtus ETF Advisers's Q32 Bio position peaked at $412K in Q4 2019.
  • 87 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2022.

Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.